Edition:
India

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

4.65USD
6 Jul 2020
Change (% chg)

-- (--)
Prev Close
$4.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
217,880
52-wk High
$6.30
52-wk Low
$2.21

Select another date:

Mon, Jul 6 2020

BRIEF-Anavex Life Sciences Announces First Participant Enrolled In Phase 1 Study Of Anavex 3-71

* ANAVEX LIFE SCIENCES ANNOUNCES FIRST PARTICIPANT ENROLLED IN PHASE 1 STUDY OF ANAVEX®3-71 (AF710B) Source text for Eikon: Further company coverage:

BRIEF-Anavex Life Says Co & Lincoln Park Capital Fund Entered Into First Amendment To Purchase Agreement

* ANAVEX LIFE SCIENCES - ON JULY 1, CO & LINCOLN PARK CAPITAL FUND, LLC ENTERED INTO FIRST AMENDMENT TO PURCHASE AGREEMENT

BRIEF-Anavex Life Sciences Announces Exceeding Of Enrollment Target For Anavex2-73 U.S. Phase 2 Rett Syndrome Clinical Trial

* ANAVEX LIFE SCIENCES ANNOUNCES EXCEEDING OF ENROLLMENT TARGET FOR THE ANAVEX®2-73 (BLARCAMESINE) U.S. PHASE 2 RETT SYNDROME CLINICAL TRIAL

BRIEF-Anavex Life Sciences Announces Initiation Of First-In-Human Phase 1 Study Of Anavex®3-71

* ANAVEX LIFE SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN PHASE 1 STUDY OF ANAVEX®3-71 (AF710B) Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Anavex Life Sciences Q2 Loss Per Share $0.12

* ANAVEX LIFE SCIENCES REPORTS FISCAL 2020 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

BRIEF-Anavex Life Sciences Corp Files Prospectus Supplement Related To Issuance, Sale Of Up To $30.3 Million In Common Shares To Lincoln Park Capital Fund, Llc

* ANAVEX LIFE SCIENCES CORP FILES PROSPECTUS SUPPLEMENT RELATES TO ISSUANCE, SALE OF UP TO $30.3 MILLION IN COMMON SHARES TO LINCOLN PARK CAPITAL FUND, LLC Source text for Eikon: [ID: https://bit.ly/3bV33mP] Further company coverage:

BRIEF-Anavex Life Sciences Corp - May Offer And Sell Shares Of Common Stock Having Offering Price Of Up To $50 Million From Time To Time

* ANAVEX LIFE SCIENCES CORP - MAY OFFER AND SELL SHARES OF COMMON STOCK HAVING OFFERING PRICE OF UP TO $50 MILLION FROM TIME TO TIME - SEC FILING Source text for Eikon: [ID: https://bit.ly/2WkFZY2] Further company coverage:

BRIEF-Anavex Life Sciences Announces Publication Of Foundational Data For Anavex®2-73 In Multiple Sclerosis

* ANAVEX LIFE SCIENCES ANNOUNCES PUBLICATION OF FOUNDATIONAL DATA FOR ANAVEX®2-73 (BLARCAMESINE) IN MULTIPLE SCLEROSIS (MS)

BRIEF-BBI Life Sciences Refers To Announcement By Co & LJ Future For Proposed Privatisation

* BBI LIFE SCIENCES CORP REFERS TO ANNOUNCEMENT BY CO & LJ FUTURE, AS OFFEROR, FOR PROPOSED PRIVATISATION OF CO

Select another date: